Fuji Pharma Co., Ltd. (4554.T) JPX
2,205.00
-2(-0.09%)
Currency In JPY
- General
- Statistics
- Historical Data
- Profile
- Financials
2,205.00
-2(-0.09%)
Currency In JPY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1658
First IPO Date
February 22, 2010
| Name | Title | Pay | Year Born |
| Shuhei Morita | President, Chief Executive Officer & Director | 0 | 1974 |
| Hitoshi Yokoyama | Executive Officer & Head of Pharmaceutical Business Division | 0 | N/A |
| Masayuki Naganawa | Managing Executive Officer & Head of Research and Development | 0 | N/A |
| Atsuya Mitsuhashi | Managing Executive Officer & Corporate Planning Department | 0 | 1971 |
| Satoshi Suzuki | Executive Vice President, Head of Business Strategy Division & Director | 0 | 1963 |
| Toyoyuki Kamide | Executive VP, Head of Corporate Management & Director | 0 | 1965 |
Fuji Pharma Co., Ltd. engages in the research and development, manufacture, and marketing of pharmaceutical products in Japan and internationally. The company offers injection agents, internal drugs, drugs for external use, and diagnostic products. It also provides medical care for women; in vitro diagnostics, acute medical care products, and curative medicines; and information regarding pharmaceuticals and health. Fuji Pharma Co., Ltd. was incorporated in 1965 and is headquartered in Tokyo, Japan.